In a recently published study, the prevalence of a panel of eight mutations in BRCA1 or BRCA2 genes, mainly detected in Ashkenazi Jewish or people from Russia or Poland, was investigated in 106 ovarian cancer patients treated at the Federal Hospital in Minas Gerais state, which is neighbour to São Paulo state. The gene discussed is BRCA2; the disease is ovarian cancer.